GLENMARK PHARMACEUTICALS LTD. - Intimation Under The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ("SEBI LODR")
Download 
|
< Back |
| 20 Nov 2020 | |
| We wish to inform you that Glenmark Pharmaceuticals Limited ('Company') has issued a notice of optional redemption to the holders of U.S. $200 million 4.5% Senior Notes due 2021 ('Notice') listed on the Singapore Exchange Securities Trading Limited, in accordance with the terms of the Indenture dated as of August 1, 2016 (as amended, supplemented, waived or otherwise modified from time to time), between, among others, the Company and Citicorp International Limited, as trustee. Copy of the Notice is<BR> attached herewith.<BR> Capitalised or other terms used but not defined herein shall, unless the context otherwise requires, have the meanings as set out in the Notice.<BR> We request you to kindly take this intimation on record and to treat the same as compliance with the applicable provisions of the SEBI LODR. | |
| View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback